Charles Decraene
Impact in
- Cancer Research top 5%
- Cancer Genomics and Diagnostics
- Oncology top 5%
- Cancer Cells and Metastasis
Papers in
-
- Cancer Genomics and Diagnostics 14
- Breast Cancer Treatment Studies 3
- Oncology 15
- Cancer Cells and Metastasis 12
- Co-authors
- Jean‐Yves PiergaGeneviève PiétuFrançois‐Clément BidardRiccardo FoddeGeert BerxMarc‐Henri SternDavid GentienOlivier Lantz
- Journals
- PLoS ONE (3 papers)Progress in Neurobiology (2 papers)Cancer Research (2 papers)BioTechniques (2 papers)Seminars in Cancer Biology (2 papers)
- Partner nations
- FranceNetherlandsUnited States
In The Last Decade
Charles Decraene
40 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 104
- Cancer Research 571
- Oncology 596
- Molecular Biology 645
- Ophthalmology 78
- Pathology and Forensic Medicine 149
Countries citing papers authored by Charles Decraene
This map shows the geographic impact of Charles Decraene's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charles Decraene with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charles Decraene more than expected).
Fields of papers citing papers by Charles Decraene
This network shows the impact of papers produced by Charles Decraene. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charles Decraene. The network helps show where Charles Decraene may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Charles Decraene, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 3 | |
| 2 | 2025 | 1 | |
| 3 | 2024 | 4 | |
| 4 | 2023 | 7 | |
| 5 | 2023 | 4 | |
| 6 | 2022 | 6 | |
| 7 | 2022 | 7 | |
| 8 | 2017 | 32 | |
| 9 | 2013 | 42 | |
| 10 | 2013 | 66 | |
| 11 | 2012 | 70 | |
| 12 | 2012 | 140 | |
| 13 | 2012 | 58 | |
| 14 | 2012 | 25 | |
| 15 | 2010 | 22 | |
| 16 | 2009 | 15 | |
| 17 | 2004 | 5 | |
| 18 | 2003 | 3 | |
| 19 | 2002 | 33 | |
| 20 | 1999 | 47 |
About Charles Decraene
Charles Decraene is a scholar working on Cancer Research, Oncology, Molecular Biology, Immunology and Allergy and Biotechnology, having authored 40 papers that have together received 1.4k indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (14 papers), Cancer Cells and Metastasis (12 papers), Gene expression and cancer classification (9 papers), Molecular Biology Techniques and Applications (8 papers), Breast Cancer Treatment Studies (3 papers), Wnt/β-catenin signaling in development and cancer (3 papers), Fibroblast Growth Factor Research (2 papers) and Cancer, Stress, Anesthesia, and Immune Response (2 papers). The work is most often cited by research in Cancer Research (571 citations), Oncology (596 citations), Molecular Biology (645 citations), Ophthalmology (78 citations) and Pathology and Forensic Medicine (149 citations). Charles Decraene has collaborated with scholars based in France, Netherlands and United States. Frequent co-authors include Jean‐Yves Pierga, Geneviève Piétu, François‐Clément Bidard, Riccardo Fodde, Geert Berx, Marc‐Henri Stern, David Gentien, Olivier Lantz, Adrien Saliou and Virginie Bernard. Their work appears in journals such as PLoS ONE, Progress in Neurobiology, Cancer Research, BioTechniques and Seminars in Cancer Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.